![\"\"](\"https:\/\/www.togetherforlife.org.al\/wp-content\/uploads\/2026\/04\/konferenca-farmaceutike-Evis-Sala.jpg\")
<\/p>\nN\u00eb Konferenc\u00ebn Mbar\u00ebkomb\u00ebtare t\u00eb Farmaceutik\u00ebs, e zhvilluar k\u00ebto dit\u00eb n\u00eb Tiran\u00eb, u vun\u00eb p\u00ebrball\u00eb dy narrativa t\u00eb ndryshme: nga nj\u00ebra an\u00eb angazhimi institucional p\u00ebr reforma dhe modernizim t\u00eb sektorit, dhe nga ana tjet\u00ebr shqet\u00ebsimet e forta t\u00eb aktor\u00ebve t\u00eb tregut p\u00ebr munges\u00eb transparence dhe problematika serioze n\u00eb funksionimin praktik t\u00eb sistemit farmaceutik.<\/p>\n
P\u00ebrfaq\u00ebsues t\u00eb industris\u00eb farmaceutike, prezent n\u00eb k\u00ebt\u00eb aktivitet, ngrit\u00ebn shqet\u00ebsime konkrete lidhur me m\u00ebnyr\u00ebn se si merren vendimet p\u00ebr \u00e7mimet e barnave dhe p\u00ebrdit\u00ebsimin e listave p\u00ebrkat\u00ebse. Sipas tyre, mungesa e informacionit dhe p\u00ebrfshirjes n\u00eb proceset vendimmarr\u00ebse krijon pasiguri n\u00eb treg, duke u reflektuar n\u00eb kaos p\u00ebr pacient\u00ebt dhe humbje ekonomike p\u00ebr farmacit\u00eb dhe bizneset farmaceutike.<\/p>\n
Nj\u00eb tjet\u00ebr problem i ngritur lidhet me p\u00ebrfshirjen e barnave pa recet\u00eb (OTC) n\u00eb rregulloren e \u00e7mimeve, nj\u00eb praktik\u00eb q\u00eb konsiderohet e pazakont\u00eb dhe q\u00eb, sipas aktor\u00ebve t\u00eb tregut, ka ndikuar n\u00eb munges\u00ebn e barnave t\u00eb njohura n\u00eb tregun vendas. Situata t\u00eb tilla kan\u00eb detyruar qytetar\u00ebt t\u00eb sigurojn\u00eb barna bazike p\u00ebrmes kanaleve informale jasht\u00eb vendit, duke d\u00ebmtuar m\u00eb tej besimin n\u00eb sistem. \u201cVet\u00ebm n\u00eb Shqip\u00ebri ndodh q\u00eb barnat OTC (barna pa recet\u00eb) t\u00eb p\u00ebrfshihen n\u00eb rregulloren e \u00e7mimeve, u shpreh Presidenti i Unionit te Biznesit Farmaceutik, z. Dorian Sadiku. Kjo ka sjell\u00eb q\u00eb n\u00eb tregun farmaceutik t\u00eb kemi munges\u00eb t\u00eb barnave nga brandet e njohura dhe katandisemi duke porositur shoke dhe miq n\u00eb Amerik\u00eb p\u00ebr t\u00eb na bler\u00eb paracetamol dhe ibubrofen.\u201d<\/p>\n
Urdhri i Farmacisteve dhe Unioni i Biznesit Farmaceutik k\u00ebrkuan ndryshime konkrete q\u00eb p\u00ebrfshijn\u00eb rritjen e transparenc\u00ebs dhe p\u00ebrfshirjen aktive t\u00eb tyre n\u00eb reform\u00ebn e tregut farmaceutik, duke ngritur shqet\u00ebsimin se mosp\u00ebrfshirja e grupeve te interesit q\u00eb n\u00eb procesin e hartimit t\u00eb legjislacionit, sjell rrezikun q\u00eb \u2018legjislacioni t\u00eb mbetet i pazbatuesh\u00ebm n\u00eb praktik\u00eb dhe t\u00eb krijoj\u00eb probleme\u201d.<\/p>\n
Nga ana tjet\u00ebr, Ministrja e Sh\u00ebndet\u00ebsis\u00eb dhe Mir\u00ebqenies Sociale, prof. Evis Sala, duke e marr\u00eb fjal\u00ebn n\u00eb Konferenc\u00eb, theksoi se reformat q\u00eb po nd\u00ebrmerren n\u00eb k\u00ebt\u00eb sektor synojn\u00eb nd\u00ebrtimin e nj\u00eb sistemi farmaceutik m\u00eb transparent, m\u00eb efikas dhe t\u00eb digjitalizuar. Sipas Ministres Sala, prioritet p\u00ebr k\u00ebt\u00eb dikaster mbetet p\u00ebrmir\u00ebsimi i aksesit n\u00eb barna inovative dhe p\u00ebrafrimi me standardet evropiane, p\u00ebr t\u00eb garantuar nj\u00ebkoh\u00ebsisht p\u00ebrballueshm\u00ebrin\u00eb e \u00e7mimeve dhe q\u00ebndrueshm\u00ebrin\u00eb e tregut.<\/p>\n
<\/p>\n
Pacient\u00ebt n\u00eb rrezik t\u00eb vazhduesh\u00ebm \u2013 q\u00eb nga mungesa e barnave deri tek barnat e skaduara<\/strong><\/p>\n P\u00ebrtej deklarimeve p\u00ebr reforma, problematikat strukturore t\u00eb sektorit farmaceutik n\u00eb Shqip\u00ebri mbeten t\u00eb theksuara. Organizata \u201cTogether for Life\u201d (TFL) ka evidentuar n\u00eb m\u00ebnyr\u00eb t\u00eb vazhdueshme, p\u00ebrmes raporteve dhe analizave, shqet\u00ebsime q\u00eb lidhen me munges\u00ebn e barnave dhe me garantimin e cil\u00ebsis\u00eb s\u00eb tyre, ve\u00e7an\u00ebrisht pas ndryshimeve ligjore t\u00eb vitit 2015, t\u00eb cilat liberalizuan tregun farmaceutik.<\/p>\n Ky liberalizim hoqi disa nga mekanizmat e m\u00ebparsh\u00ebm t\u00eb kontrollit mbi origjin\u00ebn dhe autorizimin e barnave, duke hapur rrug\u00ebn p\u00ebr hyrjen n\u00eb treg t\u00eb produkteve nga prodhues jasht\u00eb Bashkimit Evropian. Si pasoj\u00eb, jan\u00eb shtuar dyshimet dhe pasigurit\u00eb lidhur me cil\u00ebsin\u00eb dhe standardet e barnave q\u00eb qarkullojn\u00eb n\u00eb vend.<\/p>\n Raportet e Kontrollit t\u00eb Lart\u00eb t\u00eb Shtetit (KLSH) n\u00eb vite kan\u00eb evidentuar problematika t\u00eb r\u00ebnda n\u00eb sistemin farmaceutik duke l\u00ebn\u00eb detyra konkrete p\u00ebr institucionet p\u00ebrkat\u00ebse, q\u00eb nuk jan\u00eb adresuar prej tyre. N\u00eb raportin vjetor t\u00eb vitit 2025, KLSH evidenton mang\u00ebsi serioze n\u00eb funksionimin e sistemit, duke p\u00ebrfshir\u00eb munges\u00ebn e kontrollit n\u00eb zinxhirin e furnizimit dhe raste t\u00eb tregtimit t\u00eb barnave t\u00eb skaduara n\u00eb farmaci. Sipas auditimit, mbi 102 mij\u00eb nj\u00ebsi barnash me afat t\u00eb p\u00ebrfunduar kan\u00eb hyr\u00eb n\u00eb treg, duke p\u00ebrb\u00ebr\u00eb rrezik t\u00eb drejtp\u00ebrdrejt\u00eb p\u00ebr sh\u00ebndetin e pacient\u00ebve.<\/p>\n Raporti evidenton gjithashtu shp\u00ebrndarje t\u00eb barnave spitalore n\u00eb rrjetin e hapur n\u00eb kund\u00ebrshtim me ligjin, praktika t\u00eb dyshimta financiare dhe mang\u00ebsi n\u00eb menaxhimin e barnave t\u00eb rimbursueshme, p\u00ebrfshir\u00eb p\u00ebrfshirjen n\u00eb lista t\u00eb barnave pa \u00e7mim t\u00eb miratuar ose pa kontrata furnizimi.<\/p>\n Nj\u00eb nd\u00ebr gjetjet m\u00eb shqet\u00ebsuese lidhet me munges\u00ebn e barnave jetike, ve\u00e7an\u00ebrisht atyre antitumorale, ku nj\u00eb pjes\u00eb e konsiderueshme e barnave t\u00eb autorizuara nuk jan\u00eb importuar gjat\u00eb periudh\u00ebs s\u00eb auditimit. Kjo situat\u00eb d\u00ebshmon p\u00ebr nj\u00eb hendek t\u00eb thell\u00eb midis autorizimit formal dhe furnizimit real t\u00eb tregut.<\/p>\n Dhe nd\u00ebrsa institucionet flasin p\u00ebr reforma dhe modernizim, t\u00eb dh\u00ebnat n\u00eb terren tregojn\u00eb se sistemi farmaceutik p\u00ebrballet me probleme t\u00eb m\u00ebdha strukturore t\u00eb transparenc\u00ebs, menaxhimit dhe kontrollit. Pa nj\u00eb p\u00ebrfshirje reale t\u00eb aktor\u00ebve t\u00eb tregut dhe pa forcimin e mekanizmave mbik\u00ebqyr\u00ebs, rreziku \u00ebsht\u00eb q\u00eb \u00e7do reform\u00eb, sado e mir\u00eb n\u00eb k\u00ebt\u00eb sektor, t\u00eb mbeten thjesht n\u00eb nivel deklarativ. Nd\u00ebrkoh\u00eb, pacient\u00ebt do t\u00eb vijojn\u00eb t\u00eb p\u00ebrballen me mungesa, pasiguri dhe rreziqe p\u00ebr sh\u00ebndetin e tyre.<\/p>","protected":false},"excerpt":{"rendered":" N\u00eb Konferenc\u00ebn Mbar\u00ebkomb\u00ebtare t\u00eb Farmaceutik\u00ebs, e zhvilluar k\u00ebto dit\u00eb n\u00eb Tiran\u00eb, u vun\u00eb p\u00ebrball\u00eb dy narrativa t\u00eb ndryshme: nga nj\u00ebra an\u00eb angazhimi institucional p\u00ebr reforma dhe modernizim t\u00eb sektorit, dhe […]<\/p>","protected":false},"author":17,"featured_media":34917,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":"","_links_to":"","_links_to_target":""},"categories":[53],"tags":[],"class_list":["post-34916","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-publikime-shendet-dhe-mireqenie"],"yoast_head":"\n